228 related articles for article (PubMed ID: 8500713)
1. Clinical value of the determination of fasting glycocholic acid serum levels in patients with liver diseases. A comparison with standard liver tests.
Collazos J; Mendarte U; De Miguel J
Gastroenterol Clin Biol; 1993; 17(2):79-82. PubMed ID: 8500713
[TBL] [Abstract][Full Text] [Related]
2. [Clinico-diagnostic significance of the determination of bile acids in chronic liver diseases].
Andreuzzi B; Vai C; Santese R; Andreuzzi P; Cantoni L
Minerva Med; 1984 Mar; 75(13):749-56. PubMed ID: 6717831
[TBL] [Abstract][Full Text] [Related]
3. [Clinical value of determining serum levels of glycocholic acid in alcoholic lesions of the liver].
Bocharova LV; Tsodikov GV; Chernyshova NN; Kataev SS; Burkov SG
Klin Med (Mosk); 1992; 70(7-8):41-4. PubMed ID: 1460824
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic significance of fasting serum bile acid in liver disease.
Hirayama C; Irisa T; Arimura K; Nakamura M
Acta Hepatogastroenterol (Stuttg); 1976; 23(6):385-91. PubMed ID: 188286
[TBL] [Abstract][Full Text] [Related]
5. [Value of serum levels of conjugated cholic acid in the diagnosis of liver disease (author's transl)].
Wildgrube HJ; Stang H; Winkler M; Mauritz G
Dtsch Med Wochenschr; 1982 Aug; 107(33):1235-7. PubMed ID: 7106004
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of fasting serum bile acid in the long-term observation of chronic liver disease.
Kishimoto Y; Hijiya S; Takeda I
Am J Gastroenterol; 1985 Feb; 80(2):136-8. PubMed ID: 3970000
[TBL] [Abstract][Full Text] [Related]
7. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
Koruk M; Onuk MD; Akçay F; Savas MC
Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of fasting and postprandial conjugated serum cholic acid in chronic liver diseases.
Wu XN; Wang GL; Huang YZ; Wang YX; Zhou YH; Xiao SD; Zeng MD; Ren WP; Yuan JM; Xu WW
Chin Med J (Engl); 1985 Jan; 98(1):42-6. PubMed ID: 3924498
[No Abstract] [Full Text] [Related]
9. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
10. [Determination of serum bile acids in hepatobiliary diseases. Clinical applicability].
Pagani A; Pranzo A; Galante T
Minerva Med; 1984 Jan; 75(3-4):99-107. PubMed ID: 6700830
[TBL] [Abstract][Full Text] [Related]
11. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.
Bahcecioglu IH; Yalniz M; Ataseven H; Ilhan N; Ozercan IH; Seckin D; Sahin K
Hepatogastroenterology; 2005; 52(65):1549-53. PubMed ID: 16201116
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
Shiota G; Umeki K; Okano J; Kawasaki H
J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
[TBL] [Abstract][Full Text] [Related]
13. Serum lipids and lipoproteins in chronic liver disease.
Fehér J; Romics L; Jakab L; Fehér E; Szilvási I; Papp G
Acta Med Acad Sci Hung; 1976; 33(3):217-23. PubMed ID: 1031549
[TBL] [Abstract][Full Text] [Related]
14. Repeated administration of a vitamin preparation containing glycocholic acid in patients with hepatobiliary disease.
Rifai K; Ockenga J; Manns MP; Bischoff SC
Aliment Pharmacol Ther; 2006 May; 23(9):1337-45. PubMed ID: 16629939
[TBL] [Abstract][Full Text] [Related]
15. Glycocholic acid in chronic active hepatitis and mild liver diseases.
Collazos J
Clin Investig; 1993 Dec; 72(1):36-9. PubMed ID: 8136614
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of measurement of serum nuclear matrix protein levels in patients with liver disease.
Shimizu Y; Nakano I; Katano Y; Shimizu H; Fukuda Y
Hepatogastroenterology; 2005; 52(66):1809-13. PubMed ID: 16334782
[TBL] [Abstract][Full Text] [Related]
17. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection.
Giannini E; Botta F; Borro P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Mamone M; Testa R
Am J Gastroenterol; 2003 Nov; 98(11):2516-20. PubMed ID: 14638357
[TBL] [Abstract][Full Text] [Related]
18. [Utility of determining fasting and postprandial cholylglycine and sulfolithocholylglycine in the diagnosis of hepatic cirrhosis].
Martínez-Vázquez JM; Fernández-Sevilla T; Capdevila JA; Ocaña I; Ribera E; Ruibal A; Encabo G; Bacardí R
Med Clin (Barc); 1984 Mar; 82(9):392-4. PubMed ID: 6717151
[No Abstract] [Full Text] [Related]
19. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
20. Increased serum gamma-glutamyl-transpeptidase concentration is associated with nonalcoholic steatosis and not with cholestasis in patients with chronic hepatitis C.
Benini F; Pigozzi MG; Baisini O; Romanini L; Ahmed H; Pozzi A; Ricci C; Lanzini A
J Gastroenterol Hepatol; 2007 Oct; 22(10):1621-6. PubMed ID: 17845689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]